Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Nanobiotix SA

NBTX ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Mid Cap Analyst: BUY

Last Close

$38.31

▲ +0.37%

Market Cap $3.74B · Vol 27.73K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.74B

Mid Cap

Div Yield

N/A

EPS Growth

+44.63%

YoY

RSI (14)

44.42

Momentum

Beta

0.97

vs Market

52W High

$57.00

32.79% below

52W Low

$7.91

384.32% above

Volume

27.73K

Avg 27.56K

P/B

N/A

Price-to-book

ROE

31.91%

Return on equity

Free Float

100.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Nanobiotix SA (NBTX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NBTX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.24%

-8.00%

-30.43%

+51.18%

YTD

+65.70%

+376.49%

+361.57%

+187.61%

Financials & Valuation

TTM · Annual

Total Revenue	$9.21M
Net Income	$-28,143,241.00
Revenue Growth (YoY)	+123.15%
Gross Margin	100.00%
Operating Margin	-451.80%
Net Profit Margin	-305.52%
ROE	31.91%
ROA · ROIC	-35.45% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	120.02
P/B	N/A
P/FCF	N/A
EPS Growth	+44.63%
Outstanding Shares	50.62M

Technical Indicators

50-Day SMA	$37.77
200-Day SMA	$30.55
RSI (14)	44.42
Beta	0.97
52-Week High	$57.00
52-Week Low	$7.91

Volume Today	27.73K
Avg Daily Volume (30D)	27.56K
Relative Volume	1.01x
Volatility (10D)	54.69
Volatility (30D)	67.02
Free Float	100.00%

Analyst Consensus

BUY

Current Price $38.31

Mean Target $53.00

52W Low$7.91 52W High$57.00

Current

Target

$7.91 $57.00

Current Analyst target

+38.35% upside potential · 6 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00Y9D2TR2

ISINUS63009J1079

CountryFrance

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.